← FDA Drug Approvals (Drugs@FDA)

SOHONOS

NDA · New Drug Application · Sponsor: IPSEN · Approved 2023-08-16

Drug application

FDA Application #

NDA215559

Application type

New Drug Application

Brand name

SOHONOS

Generic name

PALOVAROTENE

Active ingredients

PALOVAROTENE

Dosage form

CAPSULE

Route

ORAL

Marketing status

Prescription

Sponsor

IPSEN

Manufacturer

Ipsen Biopharmaceuticals, Inc.

First approval

2023-08-16

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown